Dow Jones

40 211,72

0,53%

DAX

Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

S'inscrire

INSM

Insmed (INSM)

Insmed Inc

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:INSM

<< Précédent 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
23/04/2009	14h00	PR Newswire (US)	Insmed to Host First Quarter 2009 Conference Call	NASDAQ:INSM
21/04/2009	15h34	Marketwired	MaybachFinancial.com Posts Free Analyst Report on INSM, SEPR, UAUA and OFIX	NASDAQ:INSM	Insmed Inc
16/04/2009	22h34	Edgar (US Regulatory)	Proxy Statement (definitive) (DEF 14A)	NASDAQ:INSM	Insmed Inc
10/04/2009	22h32	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:INSM	Insmed Inc
02/04/2009	22h50	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:INSM	Insmed Inc
02/04/2009	12h01	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:INSM	Insmed Inc
31/03/2009	23h11	Edgar (US Regulatory)	Annual Report (10-K)	NASDAQ:INSM	Insmed Inc
31/03/2009	23h06	PR Newswire (US)	Insmed Completes Sale of Follow-On Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million	NASDAQ:INSM
30/03/2009	23h30	PR Newswire (US)	Insmed Announces Agreement With IDIS to Manage Expanded Access Programs for IPLEX(TM)	NASDAQ:INSM
25/03/2009	13h00	PR Newswire (US)	Insmed Announces That NASDAQ Further Extends Temporary Suspension of Minimum Bid Closing Price Rule	NASDAQ:INSM
11/03/2009	12h00	PR Newswire (US)	Insmed Announces Fourth Quarter and Full-Year 2008 Financial Results	NASDAQ:INSM
10/03/2009	18h39	PR Newswire (US)	Insmed Announces FDA Issues Statement Regarding Position on Allowing Patients With ALS Access to IPLEX(TM) Under an IND	NASDAQ:INSM
26/02/2009	14h00	PR Newswire (US)	Insmed to Host Fourth Quarter and Full-Year 2008 Conference Call	NASDAQ:INSM
12/02/2009	13h00	PR Newswire (US)	Insmed Sells Follow-on Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million	NASDAQ:INSM	Insmed Inc
12/02/2009	13h00	Business Wire	Merck & Co., Inc. Acquires Biologic Manufacturing Capabilities and Developmental Follow-on Biologics Portfolio from Insmed	NASDAQ:INSM	Insmed Inc
10/02/2009	22h54	Edgar (US Regulatory)	Annual Statement of Changes in Beneficial Ownership (5)	NASDAQ:INSM	Insmed Inc
21/01/2009	14h00	PR Newswire (US)	Insmed and Premacure Announce European Orphan Designation for IPLEX(TM) in Retinopathy of Prematurity in Infants	NASDAQ:INSM
23/12/2008	22h30	PR Newswire (US)	Insmed Announces that NASDAQ Extends Temporary Suspension of Minimum Bid Closing Price Rule	NASDAQ:INSM
25/11/2008	14h00	PR Newswire (US)	Insmed to Present at Sanford C. Bernstein Biosimilars Long View Conference	NASDAQ:INSM
18/11/2008	14h00	PR Newswire (US)	Insmed to Participate in Federal Trade Commission Roundtable on Follow-on Biologic Drugs: Framework for Competition and Continue	NASDAQ:INSM
11/11/2008	15h00	PR Newswire (US)	Beacon Equity Issues Technical Trade Alerts on Market Movers: ASTM, BRCD, DPTR, GERN, SWHC, INSM	NASDAQ:INSM	Insmed Inc
10/11/2008	14h00	PR Newswire (US)	Insmed Gains Royalty-Free Worldwide Rights for IPLEX(TM) in Connection with Potential Expanded Access ALS Programs	NASDAQ:INSM
05/11/2008	23h05	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:INSM	Insmed Inc
05/11/2008	14h00	PR Newswire (US)	Insmed to Present at Upcoming Healthcare Conferences	NASDAQ:INSM
30/10/2008	12h00	PR Newswire (US)	Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2008	NASDAQ:INSM
22/10/2008	14h00	PR Newswire (US)	NASDAQ's Temporary Suspension of Minimum Bid Closing Price Rules Extends Insmed's Compliance Date to March 20, 2009	NASDAQ:INSM
21/10/2008	14h00	PR Newswire (US)	Insmed Announces That NASDAQ Temporarily Suspends Minimum Bid Closing Price Rule	NASDAQ:INSM
20/10/2008	14h00	PR Newswire (US)	Insmed to Host Third Quarter 2008 Conference Call	NASDAQ:INSM
14/10/2008	22h30	PR Newswire (US)	Insmed Initiates Clinical Study for Follow-on Biologic Version of Neulasta(R)	NASDAQ:INSM
14/10/2008	14h05	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)	NASDAQ:INSM	Insmed Inc